Remove Clinical Trials Remove DEA Remove Epilepsy Remove THC
article thumbnail

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

Drug Enforcement Agency (DEA). According to the company’s CEO, George Hodgin, “federally legal FDA- and DEA-approved cannabis-based drugs will absolutely upend the traditional pharmaceutical market.”. Groff confirmed that it had completed its first batch of medicinal-grade cannabis for research purposes on Feb.

article thumbnail

Approval of Epidiolex Validates What Many CBD Users Already Knew

MedicalJane

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. percent of tetrahydrocannabinol (THC), the cannabinoid responsible for producing “high” psychoactive effects when consumed. The Next Move Is On The DEA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CBD: Everything You Need to Know

CannaMD

But CBD’s stolen the spotlight, partially because of its good cop/bad cop relationship with another famous cannabinoid: T etrahydrocannabinol or THC. THC is responsible for marijuana’s psychoactive effects. If you feel “high,” THC’s usually to blame. CBD Scheduling Rule Change.

CBD 100
article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Previously a Schedule I substance, hemp was reclassified; hemp has extremely low levels of THC (less than 0.3%).

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.

article thumbnail

Guest Post: Is CBD Legal? Federal & State Laws [2019]

Cannabis Law Report

Unlike marijuana which contains large quantities of the cannabinoid THC that is responsible for making you feel high, CBD will not make you high. Although the DEA refuses to remove marijuana from the schedule 1 list, the Farm Bill is considered to be the most important victory in the history of U.S. CBD is completely non-psychoactive.